Can a quick PCR test speed up lifesaving fungal infection diagnosis?

NCT ID NCT04874441

Completed Diagnosis Sponsor: University Hospital, Toulouse Source: ClinicalTrials.gov ↗

First seen Aug 11, 2026 · Last updated Aug 12, 2026 · Updated 1 time

Summary

This pilot study explores whether a PCR-based test can deliver faster results for diagnosing invasive candidiasis in intensive care patients. The trial compares the time to results using this new strategy against standard methods, with the hope of enabling earlier, more targeted antifungal treatment. Participants are non-neutropenic ICU patients with suspected candidiasis who are already receiving empirical echinocandin therapy.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: A PCR-based diagnostic test for Candida glabrata and krusei
What this could lead to: If successful, this faster diagnostic approach could help ICU patients get the right antifungal treatment sooner, potentially reducing drug resistance and healthcare costs.
What could go wrong: This is a small pilot study, so results may not apply broadly. The test's accuracy and impact on patient outcomes remain uncertain.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CANDIDA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

candidemia candidiasis disseminated candidiasis Torulopsis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CANDIDA

Contacts and locations

Locations

Uh Toulouse

Toulouse, Occitanie, 31000, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.